M&A Deal Summary |
|
|---|---|
| Date | 2020-08-31 |
| Target | TriReme Medical - Drug-coated Balloon Technology |
| Sector | Medical Products |
| Buyer(s) | Genesis MedTech |
| Sellers(s) | TriReme Medical |
| Deal Type | Divestiture |
SEARCH BY
Genesis MedTech is a medical device company focused on value segment multi-therapy medical device products for emerging markets with sales and distribution through its established commercial network. Genesis MedTech is based in Singapore.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
| Category | Company |
|---|---|
| Founded | 2005 |
| Sector | Medical Products |
TriReme Medical, Inc. (TMI) is committed to providing high-quality products for physicians to use in the treatment of coronary artery disease. Our products improve patient care by simplifying the treatment of bifurcation lesions and providing interventional cardiologists with an easy-to-use stent system that enables flexible treatment options across a broad range of bifurcation anatomies and types.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Medical Products M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| State: California M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2020 M&A | 1 of 1 |
